期刊文献+

莫西沙星与左氧氟沙星治疗耐多药肺结核患者的疗效比较 被引量:11

Comparison Efficacy of Moxifloxacin and Levofloxacin in the Treatment of Patients with Multidrug-Resistant Pulmonary Tuberculosis
下载PDF
导出
摘要 目的:比较莫西沙星与左氧氟沙星治疗耐多药肺结核(MDR-PTB)患者的临床疗效。方法:84例MDR-PTB患者根据随机数字表法分为对照组与研究组,每组42例。两组均予以常规抗结核化疗方案治疗,对照组在此基础上加用左氧氟沙星片口服治疗,观察组则加用莫西沙星片口服治疗,两组治疗时间均为12个月。比较两组治疗效果及病灶吸收、空洞闭合、痰菌转阴情况,同时记录两组治疗期间药物不良反应发生情况。结果:观察组治疗总有效率(92.86%)明显高于对照组(71.43%),差异有统计学意义(P<0.05);观察组治疗第6、9、12个月时痰菌转阴率均明显高于对照组(P<0.05);观察组病灶吸收及空洞改善情况均明显优于对照组(P<0.05);观察组药物不良反应发生率(9.52%)明显低于对照组(26.19%),差异有统计学意义(P<0.05)。结论:莫西沙星治疗MDR-PTB患者的临床疗效优于左氧氟沙星,可促进病灶吸收、空洞闭合及痰菌转阴,明显减少不良反应发生率。 Objective:To compare the clinical efficacy of Moxifloxacin and Levofloxacin in the treatment of patients with multidrug-resistant pulmonary tuberculosis(MDR-PTB).Method:84 cases of MDR-PTB patients were divided into control group and observation group according to the random number table method,42 cases in each group.Both groups were treated with conventional anti-tuberculosis chemo therapy.The control group was treated with Levofloxacin Tablets orally,while the observation group was treated with Moxifloxacin Tablets orally.Both groups were treated for 12 months.The treatment effect,focus absorption,cavity closure and sputum turning negative of the two groups were compared,and the occurrence of adverse drug reactions during the treatment of the two groups were recorded in detail.Result:The total effective rate of the observation group(92.86%)was significantly higher than that of the control group(71.43%),the difference was statistically significant(P<0.05).The turning negative rate of sputum bacteria at the 6 th,9 th and 12 th month of treatment in the observation group were significantly higher than those in the control group(P<0.05).The focus absorption and cavity improvement in the observation group were significantly better than those in the control group(P<0.05).The incidence of adverse drug reactions in the observation group(9.52%)was significantly lower than that in the control group(26.19%),the difference was statistically significant(P<0.05).Conclusion:The clinical efficacy of Moxifloxacin in the treatment of MDR-PTB patients is better than Levofloxacin.It can promote focus absorption,cavity closure and sputum turning negative,and significantly reduce the incidence of adverse reactions.
作者 郝伟 尚小三 刘纯钢 HAO Wei;SHANG Xiaosan;LIU Chungang(The Center of Disease Control and Prevention,Qianjiang 433100,China)
出处 《中国医学创新》 CAS 2019年第21期62-65,共4页 Medical Innovation of China
关键词 莫西沙星 左氧氟沙星 耐多药肺结核 Moxifloxacin Levofloxacin Multidrug-resistant pulmonary tuberculosis
  • 相关文献

参考文献20

二级参考文献141

  • 1李喜贵,刘艳香.乙型肝炎合并肺结核的治疗[J].中华腹部疾病杂志,2005,5(9):655-656. 被引量:1
  • 2朱莉贞,傅瑜,初乃惠,叶志忠,肖和平,王巍,苑松林,张侠,罗永艾,马丽萍.利福类联合多种药物长疗程方案治疗耐多药肺结核[J].中华结核和呼吸杂志,2006,29(8):520-523. 被引量:55
  • 3何国钧.多重耐药性结核病及其治疗[J].中国防痨杂志,1997,19:30-30.
  • 4张向丛,李新霞,王淑平,张笑丹,蔡兰英,邵艳欣,白云,张俊萍,高官聚.莫西沙星与左氧氟沙星对耐多药肺结核病的治疗效果[J].河北医药,2007,29(6):557-558. 被引量:28
  • 5Goble M,Iseman MD,Madsem LA,et al.Treatment of 171 patients with pulmonary tuberculosis resistant to isoniazid and rifampin[J].N Engl J Med,1993,328:527-532.
  • 6Espinal MA.Standard stort -course chemotherapy for drug-resistance tuberculosis:cheatment outcomes in 6 countries[J].JAMA,2000,238:2537-2545.
  • 7Park SK,Kim CT,Song SD.Outcome of chemotherapy in 107 patients with pulmonary tuberculosis resistant to isonazid and rifampin[J].Int J Tuberc Lung Dis,1998,2:877-884.
  • 8Moore M,Onorato IM,McCray E,et al.Trend in drug-resistant tuberculosis in the United States,1993-1996.JAMA,1997,1278:833-887.
  • 9Taylor JP,Sweat DB,Suarez L.Epidemiology of drug-resistant tuberculosis in Texas.Am J Epidemiology,1999,149:359-365.
  • 10高官聚,张广宇主编.肺结核病.第1版.长春:长春出版社,2006.6.

共引文献3159

同被引文献117

引证文献11

二级引证文献32

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部